A novel oncolytic adenovirus (Ad-hTERTp-E1a-HN) expressing NDV-HN protein can selectively inhibit esophageal cancer EC-109 cells and inhibit tumor growth in mice [56]. This evidence concerns the gene MT-RNR2 and neoplasm.